A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study

BACKGROUND: The purpose of this study was to evaluate the safety and effectiveness of iloperidone for the prevention of relapse in schizophrenia. METHODS: Study subjects were adults with schizophrenia who started on oral open-label iloperidone titrated to an initial target dose of 12 mg/day (6 mg tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiden, Peter J., Manning, Raymond, Wolfgang, Curt D., Ryan, J. Michael, Mancione, Linda, Han, Guangyang, Ahmed, Saeed, Mayo, Mallery G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982888/
https://www.ncbi.nlm.nih.gov/pubmed/27379654
http://dx.doi.org/10.1007/s40263-016-0345-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982888/
https://www.ncbi.nlm.nih.gov/pubmed/27379654
http://dx.doi.org/10.1007/s40263-016-0345-4

Ejemplares similares